Page results
-
This booklet has been written by the Autonomic Unit at The National Hospital for Neurology and Neurosurgery (NHNN). The aim of the booklet is to provide information about the 24-hour ambulatory blood pressure and heart rate (24-hr BP) monitor.
-
This patient information is intended to help patients suffering from long COVID to better manage and understand their fatigue.
-
This patient information provides possible explanations for the causes of long COVID.
-
At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.
-
This page explains how to print your information from the MyCare website and app.
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
-
Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.
-
Preterm infants do not get used to repeated pain in the way that full-term infants, children and adults do habituate to pain, finds a study at UCLH and UCL.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
The new artwork celebrates the pioneering researcher, teacher and neurology consultant at the National Hospital for Neurology and Neurosurgery.
File results
-
FOI/2022/0169 - Strategic workforce plan for recruitment and retention of Allied Health Professions
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0172 - Contraceptive pill data
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients